Product
PGV-001
1 clinical trial
1 indication
Indication
Prostate CancerClinical trial
Phase I, Open-label, Single-center Proof of Concept Study Designed to Test the Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in Combination With CDX-301 in Subjects With a History of Prostate Cancer, in the Adjuvant SettingStatus: Recruiting, Estimated PCD: 2027-01-01